Skip to main content

Veliparib

Veliparib (ABT-888) is a PARP inhibitor being investigated to treat BRCA breast cancer and ovarian cancer.

Type of Molecule

Small Molecule

Target

PARP

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Breast Cancer n/a
Phase 3
Ovarian Cancer n/a
Phase 3